Hampar B, Zweig M, Showalter S D, Bladen S V, Riggs C W
J Clin Microbiol. 1985 Apr;21(4):496-500. doi: 10.1128/jcm.21.4.496-500.1985.
A rapid and reproducible enzyme-linked immunosorbent assay (ELISA) is described for determining antibodies in human sera against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2). The sera were absorbed for 30 min with heterologous virus-infected-cell extracts to remove cross-reacting antibodies and then were applied to ELISA plates containing the target antigens, immunoaffinity-purified HSV-1 glycoproteins gC and gD and HSV-2 glycoproteins gD and gF. The absorbance index, defined as the ratio of A414 generated by a serum sample absorbed with a heterologous virus-infected-cell extract versus the A414 of a serum sample absorbed with an uninfected-cell extract, was used to determine the presence or absence of antibodies to HSV-1 and HSV-2. Results of the ELISA for detecting antibodies against HSV-2, when compared with results obtained for the same sera by the microneutralization test, showed an index of overall agreement of 91%. Results of the ELISA for detecting antibodies against HSV-1, when compared with microneutralization test results for sera negative for HSV-2 antibodies but positive for HSV antibodies by ELISA, showed an index of agreement of 99%.
本文描述了一种快速且可重复的酶联免疫吸附测定法(ELISA),用于检测人血清中针对1型单纯疱疹病毒(HSV-1)和2型单纯疱疹病毒(HSV-2)的抗体。血清先用异源病毒感染细胞提取物吸收30分钟,以去除交叉反应抗体,然后应用于含有靶抗原的ELISA板上,这些靶抗原是免疫亲和纯化的HSV-1糖蛋白gC和gD以及HSV-2糖蛋白gD和gF。吸光度指数定义为用异源病毒感染细胞提取物吸收的血清样品产生的A414与用未感染细胞提取物吸收的血清样品的A414之比,用于确定是否存在针对HSV-1和HSV-2的抗体。ELISA检测HSV-2抗体的结果与通过微量中和试验对相同血清获得的结果相比,总体一致性指数为91%。ELISA检测HSV-1抗体的结果与ELISA检测HSV-2抗体阴性但HSV抗体阳性的血清的微量中和试验结果相比,一致性指数为99%。